Valeant, Pershing Square make revised bid for Allergan

Valeant Pharmaceuticals and Pershing Square made a revised offer for Allergan on Friday that is contingent on good faith negotiations.

The offer is for $72 per share in cash and 0.83 shares of Valeant stock. Allergan halted its stock Friday ahead of the news.

Valeant stock was last lower in trade on Friday.

This is a breaking news story. Please check for further updates.

Get the latest on the markets here.